MedPath

Adeflo

Brand Name: Adeflo

Generic Name: Salmeterol (as xinafoate) + Fluticasone Propionate

Active
Registration Number

DR-XY43135

Dosage Form

Dry Powder Inhalation Capsule

Issuance Date

October 31, 2023

Expiry Date

February 20, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mcg/250 mcg
PackagingAlu/Alu Blister Pack x 8's (Box of 40's) with Inhaler

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Adrenergic in combination with corticosteroid or other drug, excluding anticholinergic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Salmeterol (as xinafoate)Active
Monograph: Salmeterol
Fluticasone PropionateActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.